The Vitrolife Group appoints Ermanno Sironi as Chief Operating Officer

REG

The COO will oversee the three business areas, Consumables, Technologies and Genetics as well as the IT organisation. The appointment supports continued execution of the corporate strategy to drive operational excellence, implementing a scalable operating model, optimising processes to realise synergies and leveraging digitalisation to increase productivity.

Ermanno Sironi is a tenured MedTech executive with over 30 years’ experience working in Operations, Finance and Business Development in global companies. Over the past year, he has served as a strategic advisor on operational excellence and business transformation to the Vitrolife Group’s executive management team.

“We are delighted that Ermanno has accepted the role of COO. His deep industry experience and strong track record of leading operational transformations will support the company to deliver on this key strategic pillar.” Bronwyn Brophy O’Connor, CEO of the Vitrolife Group.

Gothenburg, 21 February 2025
VITROLIFE AB (publ)
Bronwyn Brophy O’Connor, CEO

The information was submitted for publication, through the agency of the contact persons set out above, at 21-02-2025 13:00 CET.

Datum 2025-02-21, kl 13:00
Källa Cision
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet